DOSSIER · 13F-HR · Q1 2026

SUPERSTRING CAPITAL MANAGEMENT LP

$140M in tracked AUM across 35 positions as of Q1 2026.

SC
CIK 0001931118 · last filed Mar 31, 2026
Total AUM
$140M
as of Q1 2026
Holdings
35
positions
Whale Score
56
56
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

SUPERSTRING CAPITAL MANAGEMENT LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
SMMT
SUMMIT THERAPEUTICS INC
$17M893K12.1%
02
IMVT
IMMUNOVANT INC
$9M358K6.3%
03
COGT
COGENT BIOSCIENCES INC
$9M225K6.2%
04
SVRA
SAVARA INC
$9M1.6M6.2%
05
M96088105
UROGEN PHARMA LTD
$7M387K5.0%
06
DFTX
DEFINIUM THERAPEUTICS INC
$7M351K4.7%
07
VIR
VIR BIOTECHNOLOGY INC
$7M731K4.7%
08
PCVX
VAXCYTE INC
$6M110K4.6%
09
CLDX
CELLDEX THERAPEUTICS INC NEW
$6M180K4.1%
10
SION
SIONNA THERAPEUTICS INC
$6M141K4.0%

Filing history

2026Q1Mar 31
$140M 25.1%
35 positionsView →
2025Q4Dec 31
$187M 189.5%
45 positionsView →
2025Q3Sep 30
$65M 23.6%
24 positionsView →
2025Q2Jun 30
$84M 0.5%
36 positionsLocked
2025Q1Mar 31
$84M 27.2%
34 positionsLocked
2024Q4Dec 31
$115M 1.1%
39 positionsLocked
2024Q3Sep 30
$114M 44.0%
28 positionsLocked
2024Q2Jun 30
$79M 47.5%
39 positionsLocked
2024Q1Mar 31
$151M 7.9%
37 positionsLocked
2023Q4Dec 31
$140M
30 positionsLocked